home contact company.overview news sitemap print


NMI TT GmbH

NMI-TT Contact Person

Markwiesenstr. 55
72770 Reutlingen
Germany

Ion Channel

News

page: 1 of 10 | items: 1 to 3 | next

26.09.2016
Press Release: DigiWest multiplex protein profiling technology published in Nature Communications
Reutlingen, Germany, September 26, 2016 – The Natural and Medical Sciences Institute at the University of T├╝bingen (NMI), a private research foundation, and its contract research provider NMI TT Pharmaservices today announced the publication of their proprietary DigiWest┬« protein profiling method in the peer-reviewed scientific journal Nature Communications. [more...]

01.08.2016
6th Global Reverse Phase Protein Array Workshop
Come to Reutlingen, and hear about the latest advances in Reverse Phase Protein Arrays (RPPAs) and their application for biomarker research.
[more...]

02.05.2016
Sentinel Oncology and NMI TT Pharmaservices awarded Eurostars grant for development of a novel biomarker for treatment of Fragile X Syndrome


Cambridge/UK and Berlin/Germany, May 2, 2016 – Sentinel Oncology
and NMI TT Pharmaservices today announced that they have received grant funding for the development of a companion diagnostic to compliment the ongoing drug development activities within Sentinel Oncology for the treatment of the Fragile X Syndrome (FXS), a genetically inherited orphan disease that manifests itself in intellectual disability, for which no treatments are currently available. [more...]

 

top

NMI TT a business unit of NMI